Breast MR imaging changes after neoadjuvant chemotherapy: Correlation with molecular subtypes;Resonancia magnética de mama: Cambios en la imagen del cáncer tratado con neoadyuvancia. Correlación con subtipos moleculares

Radiologia

Volumn 54, Issue 5, 2012, Pages 442-448

  Marcos De Paz, L M ^a   Tejerina Bernal, A ^a   Arranz Merino, M L ^a   Calvo De Juan, V ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Breast cancer; Breast magnetic resonance imaging; Molecular subtypes; Neoadjuvant chemotherapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; TUMOR NECROSIS;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES;

EID: 84867399513     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/j.rx.2011.05.013     Document Type: Article

References (11)

1. S.C. Partridge, J.E. Gibbs, Y. Lu, L.J. Esserman, D. Sudilovsky, and N.M. Hylton Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy AJR Am J Roentgenol 179 2002 1193 1199
2. E.L. Rosen, K.L. Blackwell, J.A. Baker, M.S. Soo, R.C. Bentley, and D. Yu Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy AJR Am J Roentgenol 181 2003 1275 1282
3. V. Londero, M. Bazzocchi, C.D. Frate, F. Puglisi, C. Di Loreto, and G. Francescutti Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadyuvant chemotherapy Eur Radiol 14 2004 1371 1379
4. C. Sotiriou, and L. Puzstai Gene-expression signatures inbreast cancer N Engl J Med 360 2009 790 800
5. R. Rouzier, C.M. Perou, W.F. Symmans, N. Ibrahim, M. Cristofanilli, and K. Anderson Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 2005 5678 5685
6. F. Thibault, C. Nos, M. Meunier, C.E. Khoury, L. Ollivier, and B. Sigal-Zafrani MRI for surgical plannig in patients with breast cancer who undergo preoperative chemotherapy AJR Am J Roentgenol 183 2004 1159 1168
7. A. Makris, T.J. Powles, S. Kakolyris, M. Dowsett, S.E. Ashley, and A.L. Harris Reduction in angiogenesis after neoadyuvant chemoendocrine therapy in patients with operable breast carcinoma Cancer 85 1999 1996 2000
8. C. Hayes, A.R. Padhani, and M.O. Leach Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging NMR Biomed 15 2002 154 163
9. A. Rieber, H.J. Brambs, A. Gabelmann, V. Heilmann, R. Kreienberg, and T. Kühn Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy Eur Radiol 12 2002 1711 1719
10. K. Wasser, H.P. Sinn, C. Fink, S.K. Klein, H. Junkermann, and H.P. Lüdemann Accuracy of tumour size measurement in breast cancer using MRI is influenced by histological regression induced by neoadyuvant chemotherapy Eur Radiol 13 2003 1213 1223
11. A.R. Padhani, C. Hayes, L. Assersohn, T. Powles, A. Mackris, and J. Suckling Prediction of clinic pathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results Radiology 239 2006 361 374